Vyvanse and Post procedural complication - a phase IV clinical study of FDA data
Summary:
Post procedural complication is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Xyrem, and have Narcolepsy.
The phase IV clinical study analyzes which people have Post procedural complication when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.
What is Post procedural complication?
Post procedural complication is found to be associated with 1,090 drugs and 1,363 conditions by eHealthMe. Check the latest studies of Post procedural complication.
28,083 people reported to have side effects when taking Vyvanse.
Among them, 17 people (0.06%) have Post procedural complication.

Among these 17 people:
How long have people been on Vyvanse when they have Post procedural complication? *
- < 1 month: 50 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Post procedural complication when taking Vyvanse? *
- female: 78.57 %
- male: 21.43 %
What is the age of people who have Post procedural complication when taking Vyvanse? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 11.11 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 11.11 %
- 50-59: 44.44 %
- 60+: 33.33 %
What are other drugs people take besides Vyvanse? *
- Xyrem: 6 people, 35.29%
- Nuvigil: 5 people, 29.41%
- Celebrex: 5 people, 29.41%
- Lexapro: 4 people, 23.53%
- Adderall: 4 people, 23.53%
- Fosamax: 4 people, 23.53%
- Nexium: 3 people, 17.65%
- Ursodiol: 3 people, 17.65%
- Imodium: 3 people, 17.65%
- Crestor: 3 people, 17.65%
What are other side effects people have besides Post procedural complication? *
- Weight Decreased: 5 people, 29.41%
- Weight Increased: 4 people, 23.53%
- Memory Loss: 4 people, 23.53%
- Urinary Tract Infection: 4 people, 23.53%
- Stress And Anxiety: 4 people, 23.53%
- Insomnia (sleeplessness): 3 people, 17.65%
- Glucose Urine Present: 3 people, 17.65%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 17.65%
- Eating Disorder: 3 people, 17.65%
- Overgrowth Bacterial (extra growth due to bacteria): 3 people, 17.65%
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 35.29%
- Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 17.65%
- Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 11.76%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 5.88%
- Thyroid Diseases: 1 person, 5.88%
- Rickets (softening of bones): 1 person, 5.88%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
- Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 5.88%
- Ill-Defined Disorder: 1 person, 5.88%
- High Blood Cholesterol: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and have Post procedural complication?
- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vyvanse:
- Vyvanse (35,870 reports)
Post procedural complication treatments and more:
- Post procedural complication (25,253 reports)
How severe was Post procedural complication and when was it recovered:
Expand to all the drugs that have ingredients of lisdexamfetamine dimesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Post procedural complication:
- Post procedural complication (1,090 drugs)
Browse all the conditions that are associated with Post procedural complication:
- Post procedural complication (1,363 conditions)
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Januvia and Lymphadenopathy for Men aged 60+ - 7 seconds ago
- Januvia and Lymph Follicular Hypertrophy for Men aged 60+ - 7 seconds ago
- Drug interactions of Memantine and Rogaine - 10 seconds ago
- Metoprolol Tartrate and Drug Exposure During Pregnancy for Women aged 20-29 - 14 seconds ago
- Could Glucophage cause Asthma? - 15 seconds ago
- Lower Respiratory Tract Infection and drugs of ingredients of isotretinoin - 15 seconds ago
- Oxycodone vs. Talwin Nx, side effect and effectiveness comparison - 18 seconds ago
- Common Peroneal Nerve Dysfunction and drugs of ingredients of amlodipine besylate; benazepril hydrochloride - 19 seconds ago
- Xolair and Blood Urine Present for Women aged 50-59 - 20 seconds ago
- Briviact vs. Lorazepam, side effect and effectiveness comparison - 26 seconds ago